Aitor Esparza-Baquer

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms

G. Schabbauer, P. Rodrigues, J. Banales, 2020, Gut.

Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage

H. Esterbauer, A. Fontanellas, J. Banales, 2018, Gut.

Wnt–β-catenin signalling in liver development, health and disease

J. Marin, M. Marzioni, J. Banales, 2018, Nature Reviews Gastroenterology & Hepatology.

MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.

J. Banales, L. Bujanda, M. Perugorria, 2016, Clinics and research in hepatology and gastroenterology.

Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment

J. Marin, M. Marzioni, J. Banales, 2017, Digestive Diseases.

SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.

G. Gores, M. D’Amato, J. L. Lavín, 2017, Journal of hepatology.

TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation.

T. Luedde, P. Rodrigues, M. Monte, 2022, Journal of hepatology.

Characterization and genotyping of the DRB1 gene of the major histocompatibility complex (MHC) in the Marmota monax, animal model of hepatitis B.

K. Garcia-Etxebarria, G. González-Aseguinolaza, B. Jugo, 2015, Molecular immunology.

SNPs in candidate genes MX dynamin-like GTPase and chemokine (C-C motif) receptor-5 are associated with ovine pulmonary adenocarcinoma progression in Latxa sheep.

B. Jugo, E. Minguijón, A. Larruskain, 2015, Animal genetics.